HIGHLIGHTS
- who: The cientificWorldJOURNAL and colleagues from the Institute of Medicine, Medical University, Taichung, Taiwan have published the paper: A Neutral Risk on the Development of New-Onset Diabetes Mellitus (NODM) in Taiwanese Patients with Dyslipidaemia Treated with Fibrates, in the Journal: (JOURNAL)
- what: The aim of the study was to investigate the relationship between NODM and whether the fibrates lead to increased risk for developing NODM.
- how: The authors identified 145 NODM patients among 3 815 dyslipidaemic patients in database for study period. risk estimates for NODM for users of fenofibrate (HR 1 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.